Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Ann Surg. 2020 May;271(5):922-931. doi: 10.1097/SLA.0000000000003085.
Pattern recognition receptors (PRRs) on immune and parenchymal cells can detect danger-associated molecular patterns (DAMPs) released from cells damaged during ischemia-reperfusion injury (IRI), in heart attack or stroke settings, but also as an unavoidable consequence of solid organ transplantation. Despite IRI being a significant clinical problem across all solid organ transplants, there are limited therapeutics and patient-specific diagnostics currently available.
We screened portal blood samples obtained from 67 human liver transplant recipients both pre- [portal vein (PV) sample] and post-(liver flush; LF) reperfusion for their ability to activate a panel of PRRs, and analyzed this reactivity in relation to biopsy-proven IRI.
PV samples from IRI+ orthotopic liver transplantation (OLT) patients (n = 35) decreased activation of hTLR4- and hTLR9-transfected cells, whereas PV from IRI- patients (n = 32) primarily increased hTLR7 and hNOD2 activation. LF samples from OLT-IRI patients significantly increased activation of hTLR4 and hTLR9 over IRI- LF. In addition, the change from baseline reactivity to hTLR4/9/NOD2 was significantly higher in IRI+ than IRI- OLT patients.
These results demonstrate that TLR4/7/9 and NOD2 are involved in either promoting or attenuating hepatic IRI, and suggest a diagnostic screening of portal blood for reactivity to these PRRs might prove useful for prediction and/or therapeutic intervention in OLT patients before transplantation.
免疫细胞和实质细胞上的模式识别受体(PRRs)可以检测到在缺血再灌注损伤(IRI)、心脏病发作或中风情况下受损细胞释放的危险相关分子模式(DAMPs),但也作为实体器官移植不可避免的后果。尽管 IRI 是所有实体器官移植中一个重要的临床问题,但目前可用的治疗方法和针对患者的诊断方法有限。
我们对 67 名接受肝移植的患者的门静脉血样进行了筛查,这些血样分别在再灌注前(门静脉样本)和再灌注后(肝脏冲洗;LF)获得,以检测其激活一组 PRRs 的能力,并分析这种反应与活检证实的 IRI 之间的关系。
来自 IRI+原位肝移植(OLT)患者(n=35)的 PV 样本降低了 hTLR4 和 hTLR9 转染细胞的激活,而来自 IRI-患者(n=32)的 PV 样本主要增加了 hTLR7 和 hNOD2 的激活。OLT-IRI 患者的 LF 样本显著增加了 hTLR4 和 hTLR9 的激活,超过了 IRI-LF。此外,与 IRI-OLT 患者相比,IRI+OLT 患者的 hTLR4/9/NOD2 基线反应性的变化显著更高。
这些结果表明,TLR4/7/9 和 NOD2 参与促进或减轻肝 IRI,并且提示对门静脉血中这些 PRRs 的反应进行筛查可能有助于在移植前预测和/或干预 OLT 患者。